TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

HIGHBRIDGE CAPITAL MANAGEMENT LLC's Holding History (CIK: 0000919185)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 10,000,000 Value ($000) $8,631 Avg Close Range
Q2 2024
Shares 33,225,000 Value ($000) $21,216 Avg Close Range
Q1 2024
Shares 30,725,000 Value ($000) $19,993 Avg Close Range
Q4 2023
Shares 29,225,000 Value ($000) $19,033 Avg Close Range
Q3 2023
Shares 26,500,000 Value ($000) $17,217 Avg Close Range
Q2 2023
Shares 7,000,000 Value ($000) $5,701 Avg Close Range
Q1 2023
Shares 21,382,000 Value ($000) $21 Avg Close Range
Q4 2022
Shares 10,082,000 Value ($000) $9 Avg Close Range
Q3 2022
Shares 15,000,000 Value ($000) $15,310 Avg Close Range
Q2 2022
Shares 19,000,000 Value ($000) $19,009 Avg Close Range
Q1 2022
Shares 19,000,000 Value ($000) $19,967 Avg Close Range